Interval estimation for three-class Youden index with verification bias.

J Biopharm Stat

Department of Mathematics and Statistics, Georgia State University, Atlanta, Georgia, USA.

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Youden index is one of the broadly used measurements to assess the accuracy of the diagnostic test under consideration. In real medical diagnostic studies, verification of the true disease status might only be partially available due to ethical and cost considerations, and the drawbacks of gold-standard tests. Therefore, statistical evaluation of the diagnostic accuracy of a test based only on data from subjects with verified disease status is typically biased. Youden indices for the assessment of accuracy and optimal cutoff point(s) selection in diagnostic tests classifying two disease stages and three disease stages have been proposed without considering this verification bias. In this article, we develop novel confidence intervals for three-class Youden index to correct verification bias under the assumption that the true disease status, if missing, is missing at random (MAR). The proposed methods provide a comprehensive guide to dealing with the verification bias in diagnostic test accuracy studies and lead to a better choice of diagnostic tests.

Download full-text PDF

Source
http://dx.doi.org/10.1080/10543406.2025.2549361DOI Listing

Publication Analysis

Top Keywords

verification bias
16
disease status
12
three-class youden
8
diagnostic test
8
true disease
8
diagnostic tests
8
disease stages
8
diagnostic
6
verification
5
disease
5

Similar Publications

Background: Hepatitis B envelope Antigen (HBeAg) and anti-hepatitis B envelope Antigen (anti-HBe) are crucial markers for evaluating hepatitis B virus infection status and guiding clinical decisions. Considering the increasing prevalence of HBeAg-negative variants, accurate detection of both markers is essential. This study aimed to examine the analytical performance of four fully automated immunoanalyzers for the simultaneous detection of HBeAg and Anti-HBe and to assess the inter-platform concordance.

View Article and Find Full Text PDF

A Rapid Review Contrasting the Evidence on Avian Influenza A(H5Nx) Clades 2.3.4.4b and 2.3.2.1c in Humans.

Zoonoses Public Health

August 2025

Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Guelph, Ontario, Canada.

Avian influenza viruses (AIV) circulate in wild and domestic bird populations, posing an on-going risk for zoonotic transmission and virus adaptation to mammals and humans. The A(H5Nx) clades 2.3.

View Article and Find Full Text PDF

Interval estimation for three-class Youden index with verification bias.

J Biopharm Stat

August 2025

Department of Mathematics and Statistics, Georgia State University, Atlanta, Georgia, USA.

Youden index is one of the broadly used measurements to assess the accuracy of the diagnostic test under consideration. In real medical diagnostic studies, verification of the true disease status might only be partially available due to ethical and cost considerations, and the drawbacks of gold-standard tests. Therefore, statistical evaluation of the diagnostic accuracy of a test based only on data from subjects with verified disease status is typically biased.

View Article and Find Full Text PDF

Objectives: This study aimed to gain insights into the potential of using evidence from artificial intelligence (AI) in nursing support for clinical practice and decision-making and its implications for future studies.

Methods: This was a rapid review of the literature. The PubMed, CINAHL, and CENTRAL in the Cochrane Library databases were searched for randomized controlled trials (RCTs) on nursing support using AI for patient care, published between 2010 and 2024.

View Article and Find Full Text PDF

Verification of the T50 Calciprotein Crystallization test: bias estimation and interferences.

Clin Chem Lab Med

August 2025

Department of Laboratory Medicine, Laboratory Specialized Diagnostics & Research, Amsterdam UMC, Amsterdam, The Netherlands.

Objectives: The T50 Calciprotein Crystallization test (T50 test) is a novel blood-based diagnostic assay that determines the calciprotein crystallization time in patients. It is based on the one-half maximum transition time of calciprotein particle 1 (CPP1) to calciprotein particle 2 (CPP2) in serum, as detected by nephelometry. To date, the T50 test has only been performed at Calciscon AG, where the assay has been developed and is manufactured.

View Article and Find Full Text PDF